What is the upside for Extendicare's stock?
On average, they expect Extendicare's stock price to reach C$9.00 in the next twelve months. This suggests a possible upside of 6.3% from the stock's current price. View Analyst Price Targets for Extendicare.
What are analysts' target prices for Extendicare stock?
5 brokers have issued 12-month target prices for Extendicare's stock. Their forecasts range from C$7.25 to C$9.00. On average, they anticipate Extendicare's share price to reach C$8.46 in the next twelve months.
Is Extendicare Inc (Exe-T) A buy or sell?
Extendicare Inc is a Canadian stock, trading under the symbol EXE-T on the Toronto Stock Exchange (EXE-CT). It is usually referred to as TSX:EXE or EXE-T Is Extendicare Inc a buy or a sell? In the last year, 1 stock analyst published opinions about EXE-T. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock.
What is the abbreviation for Extendicare Inc?
What is Extendicare Inc stock symbol? Extendicare Inc is a Canadian stock, trading under the symbol EXE-T on the Toronto Stock Exchange (EXE-CT). It is usually referred to as TSX:EXE or EXE-T
What is Extendicare Inc stock symbol?
Extendicare Inc is a Canadian stock, trading under the symbol EXE-T on the Toronto Stock Exchange (undefined). It is usually referred to as TSX:EXE...
Is Extendicare Inc a buy or a sell?
In the last year, there was no coverage of Extendicare Inc published on Stockchase.
Is Extendicare Inc a good investment or a top pick?
Extendicare Inc was recommended as a Top Pick by null on null. Read the latest stock experts ratings for Extendicare Inc.
Why is Extendicare Inc stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should b...
Is Extendicare Inc worth watching?
0 stock analysts on Stockchase covered Extendicare Inc In the last year. It is a trending stock that is worth watching.
What is Extendicare Inc stock price?
On 2022-06-10, Extendicare Inc (EXE-T) stock closed at a price of $7.
Should I buy or sell Extendicare stock right now?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Extendicare in the last year. There are currently 4 hold ratings for the s...
What is Extendicare's stock price forecast for 2022?
4 brokerages have issued 1 year target prices for Extendicare's shares. Their forecasts range from C$8.00 to C$9.00. On average, they predict Exten...
How has Extendicare's stock performed in 2022?
Extendicare's stock was trading at C$7.30 at the start of the year. Since then, EXE stock has decreased by 4.1% and is now trading at C$7.00. View...
When is Extendicare's next earnings date?
Extendicare is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022. View our earnings forecast for Extendic...
How were Extendicare's earnings last quarter?
Extendicare Inc. (TSE:EXE) released its quarterly earnings results on Thursday, May, 12th. The company reported $0.04 earnings per share for the qu...
How often does Extendicare pay dividends? What is the dividend yield for Extendicare?
Extendicare declared a monthly dividend on Thursday, May 12th. Investors of record on Tuesday, May 31st will be paid a dividend of 0.04 per share o...
Is Extendicare a good dividend stock?
Extendicare(TSE:EXE) pays an annual dividend of C$0.48 per share and currently has a dividend yield of 6.76%. EXE has a dividend yield higher than...
Who are Extendicare's key executives?
Extendicare's management team includes the following people: Dr. Michael R. Guerriere M.D. , MBA, CEO, Pres & Director (Age 58, Pay $1.13M) Mr....
Who are some of Extendicare's key competitors?
Some companies that are related to Extendicare include Sienna Senior Living (SIA) , Nova Leap Health (NLH) , Estia Health (EHE) , Japara Health...
About Extendicare
Headlines
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada.
Extendicare (TSE:EXE) Frequently Asked Questions
Passive-Income Investing: How to Make Over $500/Month in Your Sleep! - The Motley Fool Canada
Reelcause Stock Forecast, "RCIT" Share Price Prediction Charts
6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Extendicare in the last twelve months. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Extendicare stock.
Affle (India) Stock Forecast, "AFFLE" Share Price Prediction Charts
rickolsonmusic_6824 — I wish you guys at Wallet investors would fix the funny numbers!For the confused ppl Here is the web site for reelcause: https://rcitgroup.net/They don’t have...
Cyber Apps World Stock Forecast, "CYAP" Share Price Prediction Charts
Natholal — Until now I never thought about to invest in AFFLE india stock. But when I studied the data supplied on walletinvestor.com I decided to buy...
Canadians: 3 Monthly Dividend Stocks to Hold Until 2030
baiju — Cannot understand the prices for 2021 November, December and 2022,2023... what is all this about, and how did you arrive to such figures.
3 Health-Related Stocks Pay Safe, Steady Dividends
Canadian investors are contending with market turbulence in early 2022. However, this could also provide a fantastic opportunity to buy …
Can the Healthcare Sector Rebound in 2022?
The world is still in health crisis mode to start 2022. Health officials and scientists can’t yet say what the …